Phase 3 RASolute 302 data show daraxonrasib significantly extended overall and progression free survival compared with ...
Interim Phase 1b/2a trial data support the MKK4 inhibitor's potential to protect hepatocytes and accelerate liver regeneration following surgical resection.
The FDA has approved Tivicay PD dispersible tablets for combination HIV-1 treatment in full-term neonates weighing at least 2kg.
Clinicians may not agree on physical exam findings for youth with community-acquired pneumonia (CAP), according to a study published online August 20 in JAMA Ne ...
HealthDay News — For patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer (MBC), the combination of anastrozole, palbociclib, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results